Table 1.

Summary of patient demographics and clinicopathologic features

Patient Characteristic	N (%)
Age (range)	46 (22 – 76)
Primary Tumor Size (cm)	6.5 (1 – 36.5)
Gender
Female	17 (34)
Male	33 (66)
Histology
Gastrointestinal stromal tumor	14 (28)
Leiomyosarcoma	4 (8)
Liposarcoma*	5 (10)
Synovial	3 (6)
Chondrosarcoma	3 (6)
Other	21 (42)
Original Location
Trunk	6 (12)
Abdomen/Pelvis/Retroperitoneum	30 (60)
Head & Neck	6 (12)
Extremities	8 (16)
Grade
Low	5 (10)
Intermediate/High	39 (78)
Depth
Superficial	3 (6)
Deep	45 (90)
Margins
Negative	34 (68)
Positive	13 (26)
Adjuvant Treatment
None	24 (48)
Yes	22 (44)
No Surgery	3 (6)
Disease status at MSKCC presentation
No metastases	32 (64)
Metastases	18 (36)
Tumor infiltrating lymphocytes
CD3+ (%)	3.3 (0–33.2)
CD4+ (%)	0.2 (0–13.6)
CD8+ (%)	1.2 (0–14)
FOXP3+ (%)	0.1 (0–3.6)

Abbreviations: MSKCC Memorial Sloan Kettering Cancer Center, CD 3 cluster differentiation 3, CD 4 cluster differentiation 4, CD 8 cluster differentiation 8, Nuclear transcription factor forkhead box P3 (FOXP3)

^*subtypes of liposarcoma included myxoid liposarcoma-2, dedifferentiated liposarcoma-2, well differentiated liposarcoma -1